FDA, Johnson & Johnson. Pfizer Inc., Merck & Co., Inc., and Novartis Corporation Present Best Practices at Adaptive Designs for Clinical Drug Development

PHILADELPHIA--(BUSINESS WIRE)--Organized by Pharma IQ, a division of IQPC, the Adaptive Designs for Clinical Drug Development Summit will be held April 28-30, 2010 at the Ritz Carlton in Philadelphia, PA (www.AdaptiveDesignsSummit.com). Following the much-anticipated release of the FDA’s Draft Guidance, this timely event will provide the adaptive community with an opportunity to interact with the FDA and other industry experts to determine the impact of the new Guidance. Program sessions will provide regulatory guidance as well as advise the adaptive community on how to overcome the design and implementation obstacles to adaptive development. Focused solely on adaptive clinical drug development, this event will cover regulatory updates and issues, the latest innovations and methodologies, case studies, drug supply and management, and lessons learned from real life adaptive implementation.

MORE ON THIS TOPIC